PreClinOmics

PreClinOmics TM(PCO), a Contract Research and Services Company is dedicated to providing in vivo, pre-clinical, laboratory services for the Pharmaceutical and Biotech industry, as either a primary or a secondary validation source. PCO specializes in validating test article efficacy in rodents that express complex disease disorders, such as diabetes, hypertension, hyperlipidemia, heart failure, obesity and renal failure. PCO expanded the services that it offers in the third quarter of 2003 and is now performing experimental protocols geared to determining the effectiveness of compounds solid tumor cancers.

PreClinOmics was formed in July, 2001 by the same management team and advisors that formed Genetic Models Inc., in 1991. Genetic Models brought to the research and development community such rat models as the ZDF, SHHF and ZSF1. These models are proving themselves to be excellent research subjects for the study of the etiology of diabetes, hypertension, heart failure, hyperlipidemia and kidney failure and for the demonstration of efficacy and the identification of the mechanisms of drug action. Genetic Models also performed research and drug efficacy testing services for some of its customers. Joseph Pesek, founding CEO and Richard Peterson, Ph.D. creator of the ZDF and Chairman of the Scientific Advisory Board are now providing the common thread of vision and direction for PreClinOmics as they did for Genetic Models. PreClinOmics has an expanded staff of experienced and highly qualified employees and consultants that are especially proficient in in vivo, preclinical experimental protocols. The staff is well versed in recommending appropriate rodent models for use to achieve organizational objectives and equally skilled in designing and executing these protocols.

Typical Services Offered

General

Operate in the spirit of being an extension of the sponsor's lab
Rapid response to a sponsor's inquiries
Maintain a very competitive cost structure
Tailored responses to individual sponsor needs
Specialize in rodent models
Conduct studies for efficacy, safety, and PK
Proficient in protocol design

Therapeutic Segment Knowledge

Atherosclerosis
Congestive Heart Failure
Diabetes, Type I and II
Dyslipidemia
Hypertension
Obesity
Oncology
Wound Healing

Link to PreClinOmics website: http://preclinomics.com/home.php